SEC 13F Intelligence

Dekabank Deutsche Girozentrale / EW

Dekabank Deutsche Girozentrale’s Edwards Lifesciences Corp Position

Does Dekabank Deutsche Girozentrale own Edwards Lifesciences Corp (EW)? Yes — 1.75M shares worth $142M (+0.23% of its 13F portfolio) as of Q1 2026.

Position Value
$142M
Q1 2026
Shares
1.75M
% of Portfolio
+0.23%
Quarters Held
28
currently held

Position History EW

Reported value by quarter
Q1 ’19: $9MQ1 ’19Q2 ’19: $12MQ3 ’19: $12MQ4 ’19: $10MQ1 ’20: $17MQ1 ’20Q2 ’20: $18MQ3 ’20: $28MQ1 ’21: $31MQ2 ’21: $39MQ2 ’21Q3 ’21: $37MQ4 ’21: $50MQ1 ’22: $47MQ2 ’22: $46MQ2 ’22Q3 ’22: $38MQ4 ’22: $110MQ1 ’23: $106MQ2 ’23: $131MQ2 ’23Q3 ’23: $105MQ4 ’23: $174MQ1 ’24: $188MQ2 ’24: $157MQ2 ’24Q3 ’24: $116MQ4 ’24: $131MQ1 ’25: $138MQ2 ’25: $137MQ2 ’25Q3 ’25: $134MQ4 ’25: $164MQ1 ’26: $142Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.75M$142M+0.23%
Q4 20251.75M$164M+0.28%
Q3 20251.75M$134M+0.23%
Q2 20251.75M$137M+0.24%
Q1 20251.96M$138M+0.27%
Q4 20241.75M$131M+0.24%
Q3 20241.75M$116M+0.21%
Q2 20241.68M$157M+0.28%
Q1 20241.96M$188M+0.35%
Q4 20232.28M$174M+0.36%
Q3 20231.51M$105M+0.24%
Q2 20231.41M$131M+0.29%
Q1 20231.30M$106M+0.27%
Q4 20221.47M$110M+0.29%
Q3 2022458.3K$38M+0.11%
Q2 2022484.2K$46M+0.13%
Q1 2022398.5K$47M+0.12%
Q4 2021380.1K$50M+0.12%
Q3 2021328.4K$37M+0.10%
Q2 2021382.5K$39M+0.11%
Q1 2021377.2K$31M+0.10%
Q3 2020364.2K$28M+0.13%
Q2 2020266.0K$18M+0.11%
Q1 202086.3K$17M+0.13%
Q4 201942.8K$10M+0.06%
Q3 201954.3K$12M+0.07%
Q2 201962.7K$12M+0.06%
Q1 201962.3K$9M+0.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of EW.